The EMA’s decision marks a further step in the biosimilar’s pathway to potential...
Partnerships, mergers, business combinations, and acquisitions could all be on t...
Astellas Pharma has entered a research partnership and licence agreement with Pe...
The two companies have expanded their agreement, making Teva more involved in ma...
The EMA CHMP has provided a positive opinion recommending grant of marketing aut...
Golgi Neurosciences has joined forces with Breye Therapeutics for the developmen...
Gilead Sciences and IT company Cognizant have announced an expansion of their co...
ImmunoGen has signed agreement with ImmunoBiochem for the development of next-ge...
The Ways & Means Committee package would ensure that Medicare patients pay for m...
A new lawsuit accuses Cigna of using an algorithm to automatically deny claims i...
The approach "delivers gene therapy that really addresses the root cause of dise...
Three companies that left the Pharmaceutical Research & Manufacturers of America...
A rise in cancer rates among younger people is worrying and puzzling doctors.
Roche’s announcement that it would pay $310 million for rights to a hypertension...
NIH's translational research arm is getting a new lobbyist to make sure Congress...
In this excerpt from “Random Acts of Medicine,” Anupam B. Jena and Christopher M...
